Invention Grant
- Patent Title: Pyrrolopyrimidine compounds as inhibitors of protein kinases
-
Application No.: US15435722Application Date: 2017-02-17
-
Publication No.: US10596174B2Publication Date: 2020-03-24
- Inventor: Xiao Xu , Xiaobo Wang , Long Mao , Li Zhao , Biao Xi
- Applicant: ACEA BIOSCIENCES INC.
- Applicant Address: US CA San Diego
- Assignee: ACEA THERAPEUTICS, INC.
- Current Assignee: ACEA THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Rimon, P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04 ; A61K31/52 ; A61K31/506 ; C07D473/32 ; C07D401/14 ; C07D473/34 ; C07D403/12 ; C07D239/46 ; C07D239/42 ; C07D239/47 ; C07D473/40 ; C07D487/02 ; C07D401/12 ; C07D239/48 ; C07D473/16 ; C07D473/24 ; A61K45/06
Abstract:
The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways.
Public/Granted literature
- US20170224689A1 NOVEL PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES Public/Granted day:2017-08-10
Information query
IPC分类:
